KNSA Kiniksa Pharmaceuticals, Ltd.Wall St. Analysts Ratings & Price Target
$19.40
Wall St. Ratings
-Rating: Not Covered
-Rating: Not Covered
1
Strong Sell
2
Sell
3
Hold
4
Buy
5
Strong Buy
Analysts Breakdown
Analyst in the Last 30 Days